Last reviewed · How we verify

All-in-one parenteral nutrition

Fujian Shengdi Pharmaceutical Co., Ltd. · Phase 3 active Small molecule

All-in-one parenteral nutrition is a Parenteral nutrition formulation Small molecule drug developed by Fujian Shengdi Pharmaceutical Co., Ltd.. It is currently in Phase 3 development for Nutritional support in patients unable to tolerate enteral feeding, Post-operative nutritional support, Critical illness requiring total parenteral nutrition.

All-in-one parenteral nutrition provides complete macronutrient and micronutrient support intravenously for patients unable to eat or absorb nutrients orally.

All-in-one parenteral nutrition provides complete macronutrient and micronutrient support intravenously for patients unable to eat or absorb nutrients orally. Used for Nutritional support in patients unable to tolerate enteral feeding, Post-operative nutritional support, Critical illness requiring total parenteral nutrition.

At a glance

Generic nameAll-in-one parenteral nutrition
SponsorFujian Shengdi Pharmaceutical Co., Ltd.
Drug classParenteral nutrition formulation
ModalitySmall molecule
Therapeutic areaNutrition support / Critical care
PhasePhase 3

Mechanism of action

This formulation combines amino acids, glucose, lipids, electrolytes, vitamins, and trace elements in a single bag or container for intravenous administration. It is designed to meet total nutritional requirements for patients with severe gastrointestinal dysfunction, post-surgical recovery, or critical illness, eliminating the need for multiple separate infusions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about All-in-one parenteral nutrition

What is All-in-one parenteral nutrition?

All-in-one parenteral nutrition is a Parenteral nutrition formulation drug developed by Fujian Shengdi Pharmaceutical Co., Ltd., indicated for Nutritional support in patients unable to tolerate enteral feeding, Post-operative nutritional support, Critical illness requiring total parenteral nutrition.

How does All-in-one parenteral nutrition work?

All-in-one parenteral nutrition provides complete macronutrient and micronutrient support intravenously for patients unable to eat or absorb nutrients orally.

What is All-in-one parenteral nutrition used for?

All-in-one parenteral nutrition is indicated for Nutritional support in patients unable to tolerate enteral feeding, Post-operative nutritional support, Critical illness requiring total parenteral nutrition.

Who makes All-in-one parenteral nutrition?

All-in-one parenteral nutrition is developed by Fujian Shengdi Pharmaceutical Co., Ltd. (see full Fujian Shengdi Pharmaceutical Co., Ltd. pipeline at /company/fujian-shengdi-pharmaceutical-co-ltd).

What drug class is All-in-one parenteral nutrition in?

All-in-one parenteral nutrition belongs to the Parenteral nutrition formulation class. See all Parenteral nutrition formulation drugs at /class/parenteral-nutrition-formulation.

What development phase is All-in-one parenteral nutrition in?

All-in-one parenteral nutrition is in Phase 3.

What are the side effects of All-in-one parenteral nutrition?

Common side effects of All-in-one parenteral nutrition include Hyperglycemia, Catheter-related infection, Hepatic dysfunction, Electrolyte imbalances, Lipid emulsion-related adverse effects.

Related